The specificity of platelet glutamate receptor supersensitivity in psychotic disorders

被引:41
作者
Berk, M [1 ]
Plein, H
Belsham, B
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Dept Psychiat, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Dept Clin & Expt Pharmacol, ZA-2193 Johannesburg, South Africa
关键词
schizophrenia; mania; depression; psychosis; platelet intracellular calcium response; glutamate; receptor supersensitivity;
D O I
10.1016/S0024-3205(00)80002-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypoglutamatergic function is implicated in the pathogenesis of schizophrenia, and supersensitivity of platelet NMDA receptors has been reported in schizophrenia. The aim of this study was to examine the platelet glutamate receptor sensitivity in patients with schizophrenia (n=12), mania with psychotic features (n=10) and depression with psychotic features (n=10) and matched controls (n=12) in order to assess if this is a marker of schizophrenia or occurs in other psychotic conditions. Glutamate receptor sensitivity was assessed using the intracellular calcium response to glutamate measured with spectroflourometry. The percentage response of the schizophrenic and depressed psychotic subjects to glutamate stimulation was significantly greater than control subjects (p<0.005). The mania with psychotic features group was not significantly different to controls. This data suggests that platelet glutamate receptors may be supersensitive in schizophrenia and depression with psychotic features. Furthermore, the platelet may be a possible peripheral marker of glutamate function in schizophrenia and depression with psychotic features.
引用
收藏
页码:2427 / 2432
页数:6
相关论文
共 20 条
[1]  
ALMAZOV V A, 1988, Biokhimiya, V53, P848
[2]   Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia [J].
Berk, M ;
Plein, H ;
Csizmadia, T .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) :119-122
[3]   THE PLATELET INTRACELLULAR CALCIUM RESPONSE TO SEROTONIN IS AUGMENTED IN BIPOLAR MANIC AND DEPRESSED-PATIENTS [J].
BERK, M ;
BODEMER, W ;
VANOUDENHOVE, T ;
BUTKOW, N .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1995, 10 (03) :189-193
[4]   A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, GS ;
Ascher, JA ;
Monaghan, E ;
Rudd, GD .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :79-+
[5]  
DUBOVSKY SL, 1989, ARCH GEN PSYCHIAT, V46, P632
[6]  
Grant ER, 1997, J BIOL CHEM, V272, P647
[7]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[8]   Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia [J].
HerescoLevy, U ;
Javitt, DC ;
Ermilov, M ;
Mordel, C ;
Horowitz, A ;
Kelly, D .
BRITISH JOURNAL OF PSYCHIATRY, 1996, 169 (05) :610-617
[9]   NMDA GLUTAMATERGIC RECEPTORS, LABELED WITH [H-3] MK-801, IN BRAIN SAMPLES FROM DRUG-FREE DEPRESSED SUICIDES [J].
HOLEMANS, S ;
DEPAERMENTIER, F ;
HORTON, RW ;
CROMPTON, MR ;
KATONA, CLE ;
MALOTEAUX, JM .
BRAIN RESEARCH, 1993, 616 (1-2) :138-143
[10]  
JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301